{
    "2018-06-20": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Novo Nordisk in Deal with Kallyope for Obesity, Diabetes Drugs",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Kallyope",
                        "Obesity",
                        "Diabetes",
                        "Drugs"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Novo Nordisk Announces Completion, Headline Results Of Phase 3a Trials PIONEER 4",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Phase 3a Trials",
                        "PIONEER 4",
                        "Completion",
                        "Headline Results"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "LLY vs. NVO: Which Stock Should Value Investors Buy Now?",
                "features": {
                    "keywords": [
                        "LLY",
                        "NVO",
                        "Value Investors",
                        "Stock"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "investing"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}